Dupuytren's Contracture: Bacterial Collagenase Treatment

We are studying a new bacterial collagenase injection for patients with Dupuytren's contracture to see if it improves hand function and reduces contracture compared to a placebo.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Vibrio Alginolyticus Collagenase

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Medical University Of Graz
Klinische Abteilung für Plastische, Ästhetische und Rekonstruktive Chirurgie
Graz, Austria
Noe LGA Gesundheit Region Mitte GmbH
Klinische Abteilung für Plastische, Ästhetische und Rekonstruktive Chirurgie
Sankt Pölten, Austria
Helios Klinikum Bonn/Rhein-Sieg
Klinik für Hand- und Plastische Chirurgie
Alfter, Germany

Sponsor: Fidia Farmaceutici S.p.A.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.